Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
107 result(s) found, displaying 76 to 100
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper.
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2020
-
Corporate reportsThe Health Products Regulation Group has published a new regulatory science strategy
-
Corporate reportsOur plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
-
Scheduling decisions (final)Final decision in relation to risankizumab
-
Scheduling decisions (final)Recommendations for the scheduling of New Chemical Entities for inclusion in the Poisons Standard
-
TGA laboratory testing reportsThe TGA Laboratories has published a detailed report related to the testing of measles vaccines available in Australia
-
Corporate reportsThe TGA has finalised the outcomes of the Lower Risk Registered OTC Products Review Pilot Project
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 16 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 17 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 5 statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the fifth time on 5 August 2014
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 300 statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 296 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 297 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 299 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 298 statement
-
Corporate reportsThis statement guides decision making to help address concerns with joint replacement prostheses.
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 4 statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACCS#10 and the joint ACCS-ACMS#8
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS
-
Meeting statementsTherapeutic Goods Committee, 20 June 2014, meeting statement